Literature DB >> 11503011

Influence of the variable number of tandem repeats located in the promoter region of the thiopurine methyltransferase gene on enzymatic activity.

S Alves1, A Amorim, F Ferreira, M J Prata.   

Abstract

BACKGROUND: The genetic polymorphism of thiopurine methyltransferase (TPMT) activity has a significant relevance in the clinical outcome of patients receiving thiopurine drugs as immunosupressive or anticancer therapies. Apart from several open reading frame mutations unequivocally associated with decreased TPMT activity, a variable number of tandem repeats (VNTR), located within the 5' untranslated region, was recently reported as also affecting gene expression. AIMS AND METHODS: We have characterized both molecularly, by polymerase chain reaction-based techniques, and enzymatically, with an HPLC-based method, a sample of 143 Portuguese Caucasian individuals with the main objective of deepening the study of the TPMT genotype/phenotype relationship. Because two different repeated elements (A and B) do contribute to the overall VNTR variation, we set out to analyze their combined and individual effects on TPMT activity.
RESULTS: Allele VNTR*6 was found to be consistently associated with decreased levels of TPMT activity, supporting previous reports that the VNTR does affect levels of TPMT activity, although moderately and in a way not yet clearly defined. Furthermore, individual analysis of the A and B variations suggested that three B repeats was the likely motif influencing gene expression toward decreased transcription.
CONCLUSIONS: Our hypothesis, which emphasizes the number of particular motifs within the VNTR internal structure more than the undiscriminated number of repeats as the potential causative factor affecting TPMT activity, needs further support from future studies, namely, from enlarged population samples. However, the knowledge of the VNTR acting mechanism will represent an important step toward fully understanding how the phenotypic variability at the TPMT trait is modulated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11503011     DOI: 10.1067/mcp.2001.117284

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  16 in total

1.  Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significance.

Authors:  Sandeep Kirit Davavala; Devendra C Desai; Philip Abraham; Tester Ashavaid; Anand Joshi; Tarun Gupta
Journal:  Indian J Gastroenterol       Date:  2013-08-31

Review 2.  The role of pharmacogenetics in cancer therapeutics.

Authors:  Wei Peng Yong; Federico Innocenti; Mark J Ratain
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

3.  Phenotyping and genotyping studies of thiopurine S-methyltransferase in Kazaks.

Authors:  Hong Wei; Shufeng Zhou; Chengrong Li; Jianping Zhang; Jueheng Wu; Min Huang
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

Review 4.  Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.

Authors:  Tessa M Bosch; Irma Meijerman; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 5.  Very important pharmacogene summary: thiopurine S-methyltransferase.

Authors:  Liewei Wang; Linda Pelleymounter; Richard Weinshilboum; Julie A Johnson; Joan M Hebert; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2010-06       Impact factor: 2.089

Review 6.  The thiopurines: an update.

Authors:  Sally Coulthard; Linda Hogarth
Journal:  Invest New Drugs       Date:  2005-12       Impact factor: 3.850

7.  Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients.

Authors:  Hua-Wen Xin; Hui Xiong; Xiao-Chun Wu; Qing Li; Lei Xiong; Ai-Rong Yu
Journal:  Eur J Clin Pharmacol       Date:  2008-12-02       Impact factor: 2.953

8.  Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: a systematic review.

Authors:  Lilla M Roy; Richard M Zur; Elizabeth Uleryk; Chris Carew; Shinya Ito; Wendy J Ungar
Journal:  Pharmacogenomics       Date:  2016-03-29       Impact factor: 2.533

9.  Real-time RT-PCR methodology for quantification of thiopurine methyltransferase gene expression.

Authors:  Malin Lindqvist; Sven Almer; Curt Peterson; Peter Söderkvist
Journal:  Eur J Clin Pharmacol       Date:  2003-06-19       Impact factor: 2.953

10.  Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age.

Authors:  Catherine Ganiere-Monteil; Yves Medard; Corinne Lejus; Béatrice Bruneau; Alain Pineau; Odile Fenneteau; Michel Bourin; Evelyne Jacqz-Aigrain
Journal:  Eur J Clin Pharmacol       Date:  2004-03-12       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.